BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.
Clinical trial NCT07474961 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07474961
- Sponsor
- Anne Louise Tølbøll Sørensen
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2027-03-01
- Primary completion
- 2036-12-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.